Becton Dickinson (BDX) Cash & Current Investments (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Cash & Current Investments of $816.0 million for Q1 2026, up 9.24% year-over-year from $747.0 million in Q1 2025, and up 8.66% quarter-over-quarter from $751.0 million in Q4 2025.
Becton Dickinson (BDX) Cash & Current Investments (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Cash & Current Investments for 18 consecutive years, with $816.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 9.24% year-over-year to $816.0 million; the TTM figure through Mar 2026 stood at $816.0 million (up 9.24% YoY), while the FY2025 annual figure was $575.0 million, down 69.02% from the prior year.
- Cash & Current Investments climbed to $816.0 million in Q1 2026 per BDX's latest filing, from $751.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $5.3 billion in Q2 2024 and bottomed at $575.0 million in Q3 2025.
- Historically, Cash & Current Investments has averaged $1.6 billion across 5 years, with a median of $1.2 billion in 2022.
- Annual changes were most pronounced in 2024 — Cash & Current Investments soared 418.55% — and 2025, when it plunged 84.99%.
- Becton Dickinson's Cash & Current Investments stood at $612.0 million in 2022, then surged by 93.14% to $1.2 billion in 2023, then tumbled by 38.41% to $728.0 million in 2024, then advanced by 3.16% to $751.0 million in 2025, then rose by 8.66% to $816.0 million in 2026.
- Business Quant data shows BDX's Cash & Current Investments at $816.0 million in Q1 2026, $751.0 million in Q4 2025, and $575.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 863.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.68 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 1.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 863.00 Mn |
| Mar 31, 2026 | 816.00 Mn |
| Dec 31, 2025 | 751.00 Mn |
| Sep 30, 2025 | 575.00 Mn |
| Jun 30, 2025 | 797.00 Mn |
| Mar 31, 2025 | 747.00 Mn |
| Dec 31, 2024 | 728.00 Mn |
| Sep 30, 2024 | 1.86 Bn |
| Jun 30, 2024 | 5.31 Bn |
| Mar 31, 2024 | 2.39 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.48 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.99 Bn |
| Dec 31, 2022 | 612.00 Mn |
| Sep 30, 2022 | 1.16 Bn |
| Jun 30, 2022 | 2.76 Bn |
| Mar 31, 2022 | 3.32 Bn |
| Dec 31, 2021 | 2.05 Bn |
| Sep 30, 2021 | 2.39 Bn |